Alchemyca Biotech | $2,500,000 | (Nov 22, 2024)
Dote | $1,447,585 | (Nov 22, 2024)
Iontra Inc | $45,000,000 | (Nov 22, 2024)
Ossium Health
United States
- San Francisco, California
- 26/07/2023
- Series C
- $52,000,000
Building a Healthier Future
Our mission is to improve the health, vitality, and longevity of human beings through bioengineering.
Who We Are
At Ossium, we believe that science is humanity’s best weapon in the fight against disease, and we embrace the challenge of mobilizing the world’s healthcare ecosystem to win that fight. In pursuit of this goal, we empower our employees, maintain the highest standards of excellence, and are a force for good.
PRINCIPLES
The values we live by
Impact
We are mission-driven and results-oriented. We believe that a healthier world is a better one and that our work should drive positive change.
Truth
Embracing the truth empowers us to learn from both our successes and our mistakes. We follow the data wherever it leads.
Ownership
We hold ourselves and each other to the highest bar. We care deeply about the work we do and know that even the smallest details can make a difference.
- Industry Biotechnology Research
- Website https://ossiumhealth.com/
- LinkedIn https://www.linkedin.com/company/ossiumhealth/
Related People
Kevin CaldwellCo Founder
United States -
San Francisco Bay Area
Kevin Caldwell is Co-Founder & CEO of Ossium Health, where he leads the team that is building the world’s first bank of life saving, on-demand bone marrow stem cells for transplant. This new source of bone marrow will enable immunosuppresion-free organ transplants, improved blood cancer therapies, rapid response radiation injury treatment and other novel uses.
Prior to founding Ossium, Kevin worked as an Engagement Manager at McKinsey’s San Francisco office where he served clients in the technology sector. Before McKinsey, Kevin served as a Senior Investment Associate at Bridgewater Associates where he did quantitative research for the firm’s global macro investment strategy. Kevin holds degrees from MIT and Harvard Law School.
When he’s not building companies to tackle the world’s problems, Kevin enjoys science fiction novels, hang gliding, and exploring the beautiful Northern California coast
Enveda | $130,000,000 | (Nov 22, 2024)
Shinami | $5,645,000 | (Nov 22, 2024)
DANNCE.ai | $2,600,000 | (Nov 22, 2024)
Trustero | $10,000,000 | (Nov 22, 2024)
Lighthouse (UK) | $370,000,000 | (Nov 22, 2024)
Faircraft | $15,800,000 | (Nov 22, 2024)
Clean Skin Club | $32,000,000 | (Nov 22, 2024)
KeySavvy | $4,250,000 | (Nov 22, 2024)
Prompt Security | $18,000,000 | (Nov 21, 2024)